Premium
The protective effect of inhaled BRL 10833 on allergen induced bronchospasm
Author(s) -
PAUWELS R.,
LAMONT H.,
STRAETEN M.
Publication year - 1976
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1976.tb01930.x
Subject(s) - bronchospasm , inhalation , allergen , medicine , asthma , bronchial spasm , immunology , allergy , pharmacology , anesthesia
Summary BRL 10833, a nitroindanedione, with similar inhibitory activities to DSCG on the immediate type IgE mediated hypersensitivity in the rat, has been shown, when inhaled in a dose of 40 mg, to protect against allergen induced bronchospasm. A significant protective effect of BRL 10833 on the immediate bronchial reaction was seen in five out of ten patients. A single inhalation of 40 mg BRL 10833 seems also to have some protective effect on the late bronchial reaction, following an immediate reaction.